SCHEMBL19923652

SCHEMBL19923652

CCC1(C)C(=O)N(C)C(=O)N1[Si](c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.38
CYP2C19 P33261 1/20 0.38
LMNA P02545 2/20 0.37
ELANE P08246 5/20 0.36
NPSR1 Q6W5P4 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.35
ALDH1A1 P00352 4/20 0.33
BACE1 P56817 2/20 0.33
PLA2G7 Q13093 1/20 0.33
REN P00797 1/20 0.33
APP P05067 1/20 0.33
BACE2 Q9Y5Z0 1/20 0.33
GRM5 P41594 1/20 0.32
MAPT P10636 1/20 0.31
MAPK1 P28482 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
HSD17B10 Q99714 1/20 0.31
KDM4C Q9H3R0 1/20 0.31
KDM4E B2RXH2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19923686 0.81 ALDH1A1 (0.37) TSHRCYP2C19LMNAELANEL3MBTL1
SCHEMBL19923754 0.77 HTR1A (0.41) TSHRCYP2C19LMNAALDH1A1BACE1
SCHEMBL19923600 0.75 LMNA (0.32) LMNAALDH1A1KDM4E
SCHEMBL19923727 0.74
SCHEMBL19923547 0.71 ELANE (0.49) TSHRCYP2C19LMNAELANENPSR1
SCHEMBL19923436 0.71
SCHEMBL19923709 0.71 NPSR1 (0.40) TSHRCYP2C19LMNAELANENPSR1
SCHEMBL19923515 0.68 ALDH1A1 (0.37) ELANEALDH1A1PLA2G7
SCHEMBL19923573 0.68 HTR1A (0.43) TSHRCYP2C19LMNAL3MBTL1ALDH1A1
SCHEMBL19923748 0.68 NPSR1 (0.40) TSHRCYP2C19LMNAELANENPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10899718-B2 Polymers functionalized with N-protected hydantoin compounds BRIDGESTONE CORPORATION (JP) 2021-01-26 US claimed
US-20180065935-A1 POLYMERS FUNCTIONALIZED WITH N-PROTECTED HYDANTOIN COMPOUNDS BRIDGESTONE CORPORATION (JP) 2018-03-08 US claimed
US-10899718-B2 Polymers functionalized with N-protected hydantoin compounds BRIDGESTONE CORPORATION (JP) 2021-01-26 US disclosed
US-20180065935-A1 POLYMERS FUNCTIONALIZED WITH N-PROTECTED HYDANTOIN COMPOUNDS BRIDGESTONE CORPORATION (JP) 2018-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180065935-A1 POLYMERS FUNCTIONALIZED WITH N-PROTECTED HYDANTOIN COMPOUNDS PARG, HNMT, PARN TSHR 4786/4885CYP2C19 1347/4885LMNA 336/4885
US-10899718-B2 Polymers functionalized with N-protected hydantoin compounds HNMT, PARG, PAM TSHR 4794/4885CYP2C19 1259/4885LMNA 455/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.